Global Cardiac Ablation Devices Market: Size & Forecast with Impact Analysis of COVID-19 (2020-2024)

Global Cardiac Ablation Devices Market: Size & Forecast with Impact Analysis of COVID-19 (2020-2024)

  • October 2020 •
  • 86 pages •
  • Report ID: 5982049 •
  • Format: PDF
Scope of the Report
The report entitled “Global Cardiac Ablation Devices Market: Size & Forecast with Impact Analysis of COVID-19 (2020-2024)”, provides in-depth analysis of the global cardiac ablation devices, with detailed analysis of market size and growth. The report provides analysis of the cardiac ablation devices market by value, by volume, by application, by procedures & by region. The report further provides detailed regional analysis of the cardiac ablation devices market by value, by volume and by procedures.

Moreover, the report also evaluates the major opportunities in the market and outlines the factors that are and would be driving the growth of the industry. Growth of the overall global cardiac ablation devices has also been forecasted for the years 2020-2024, taking into consideration the previous growth patterns, the growth drivers and the current & future trends.

Some of the major players operating in global cardiac ablation devices market are Johnson & Johnson (Biosense Webster), Abbott Laboratories Inc., Medtronic Plc and Boston Scientific Corporation, whose company profiling has been done in the report. Furthermore, in this segment of the report, business overview, financial overview and business strategies of the respective companies are also provided.

Region Coverage
North America
APAC
Europe
ROW

Company Coverage
Johnson & Johnson (Biosense Webster)
Abbott Laboratories Inc.
Medtronic Plc
Boston Scientific Corporation

Executive Summary
There are different types of cardiac ablation procedures for the treatment of patients such as atrial flutter ablation, pulmonary vein isolation, supraventricular tachycardia (SVT) ablation, and ventricular tachycardia ablation.

The cardiac ablation devices market is segmented on the basis of procedures and application. On the basis of procedures, the market is bifurcated into atrial flutter ablation, supraventricular tachycardia (SVT) ablation, and ventricular tachycardia ablation, and on the basis of application the market is divided into open heart surgery, cardiac rhythm management and others.

The global cardiac ablation devices market has observed progressive growth in the past few years and it is expected that during the forecasted period (2020-2024) the market would further augment at an escalating growth rate. The global cardiac ablation devices market growth is anticipated to be supported by numerous growth drivers such as surging geriatric population, rising global healthcare expenditure, augmenting obese population, escalating prevalence of cardiovascular disease, increasing diabetic population and many other factors.

Though, the growth of global cardiac ablation devices market would be negatively impacted by various challenges. Some of the foremost challenges faced by the market are regulatory obligations and risk associated with cardiac ablation. Moreover, there are some trends that would support the market during the forecasted period are, technological advances for catheter ablation and radiofrequency (RF) monitoring tool for cardiac procedures.